FDA Drug Application (204078) for BLOXIVERZ by ECLAT PHARMS LLC

Back to FDA Applications sponsored by ECLAT PHARMS LLC

Application Number204078
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage5MG/10ML (0.5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameBLOXIVERZ
Active IngredientNEOSTIGMINE METHYLSULFATE

Active IngredientCount
List of drugs with Active Ingredient NEOSTIGMINE METHYLSULFATE2


Back to FDA Applications sponsored by ECLAT PHARMS LLC